Entero Healthcare Solutions Limited announced the outcome of its Board Meeting held on August 7, 2026. The Board approved the unaudited financial results for the quarter ended June 30, 2026, along with limited review reports. Key decisions also included the reconstitution of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, effective August 25, 2026.
Board Meeting Outcome
Entero Healthcare Solutions Limited convened a Board Meeting on August 7, 2026, where several key corporate actions were approved. The primary focus was the consideration and approval of the unaudited financial results for both standalone and consolidated operations for the quarter ending June 30, 2026. These results were accompanied by unmodified limited review reports from the company’s statutory auditors.
Committee Reconstitutions
In light of the completion of Mr. Rajesh Shashikant Dalal’s tenure as a Non-Executive Independent Director on August 24, 2026, the Board approved the reconstitution of its key committees. The changes are effective from August 25, 2026:
Audit Committee
- Chairperson: Sandhya Gadkari Sharma
- Member: Sujesh Vasudevan
- Member: Prabhat Agrawal (Managing Director & CEO)
Nomination and Remuneration Committee
- Chairperson: Sandhya Gadkari Sharma
- Member: Sujesh Vasudevan
- Member: Arun Sadhanandham
Stakeholders Relationship Committee
- Chairperson: Sujesh Vasudevan
- Member: Arun Sadhanandham
- Member: Prem Sethi (Whole Time Director & COO)
Financial Highlights (Standalone)
For the quarter ended June 30, 2026, Entero Healthcare reported a total income of ₹1,064.11 million, with expenses totaling ₹1,018.06 million. Profit before exceptional items and tax stood at ₹46.05 million. The profit for the period after tax was ₹34.57 million.
Earnings per share (Face value ₹10) for the quarter were ₹0.79 (basic and diluted). The company’s paid-up equity share capital remained stable at ₹435.23 million.
Financial Highlights (Consolidated)
On a consolidated basis for the quarter ended June 30, 2026, the Group’s total income reached ₹19,435.02 million, with total expenses at ₹18,763.82 million. This resulted in a profit before exceptional items and tax of ₹671.20 million. The profit for the period after tax was ₹520.51 million.
Consolidated earnings per share (Face value ₹10) were ₹8.77 (basic) and ₹8.76 (diluted). Total comprehensive income for the period stood at ₹519.21 million. The Group’s paid-up equity share capital was ₹435.23 million.
Source: BSE
